TG THERAPEUTICS INC (TGTX) Stock Income Statement
NASDAQ:TGTX - US88322Q1085 - Common Stock
29.445 USD
+0.68 (+2.35%)
29.4 USD
-0.05 (-0.15%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 454.07M | 329.00M | 233.66M | 2.79M | 6.69M | |||
| Cost Of Goods | 59.22M | 38.49M | 14.13M | 265.00K | 790.00K | |||
| Gross Profit | 394.85M | 290.52M | 219.53M | 2.52M | 5.90M | |||
| Operating Expenses | 309.00M | 248.59M | 198.90M | 220.84M | 350.67M | |||
| Research and Development | 122.16M | 94.29M | 76.19M | 125.35M | 222.58M | |||
| Selling, General, and Administrative Expenses | 186.84M | 154.30M | 122.71M | 95.48M | 128.09M | |||
| Operating Income | 85.85M | 41.93M | 20.63M | -218.32M | -344.77M | |||
| Interest Income/Expense | -31.37M | -24.03M | -12.62M | -10.19M | -5.64M | |||
| Other Income/Expense | 11.63M | 7.69M | 5.04M | 4.70M | 2.31M | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | 66.11M | 25.59M | 13.06M | -223.81M | -348.10M | |||
| Income Tax | 5.65M | 2.21M | 390.00K | 0.00 | N/A | |||
| Net Income | 60.46M | 23.38M | 12.67M | -223.81M | -348.10M | |||
| EBITDA | 85.89M | 42.00M | 20.84M | -218.01M | -344.49M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 0.37 | 0.15 | 0.09 | -1.65 | -2.63 | |||
| Non GAAP EPS | 0.37 | 0.14 | 0.01 | -1.46 | -2.63 | |||
| Statistics | ||||||||
| Gross Profit Margin | 86.96% | 88.30% | 93.95% | 90.48% | 88.19% | |||
| Profit Margin | 13.31% | 7.11% | 5.42% | -8036.34% | -5204.08% | |||
| Operating Profit Margin | 18.91% | 12.74% | 8.83% | -7838.99% | -5154.28% | |||
All data in USD